Risk assessment and management of genetically modified organisms under Australia's Gene Technology Act: Considerations for regulatory development

Compared to both Canada and the United States, Australia has been slow to approve commercial planting of transgenic crops. Two probable reasons exist for the slow approval rate of transgenic crops in Australia. The first reason is community perceptions about the risks associated with transgenic tech...

Descripción completa

Detalles Bibliográficos
Autores principales: Linacre, Nicholas A., Falck-Zepeda, José B., Komen, John, MacLaren, Donald
Formato: Journal Article
Lenguaje:Inglés
Publicado: 2006
Materias:
Acceso en línea:https://hdl.handle.net/10568/172245
_version_ 1855538640409591808
author Linacre, Nicholas A.
Falck-Zepeda, José B.
Komen, John
MacLaren, Donald
author_browse Falck-Zepeda, José B.
Komen, John
Linacre, Nicholas A.
MacLaren, Donald
author_facet Linacre, Nicholas A.
Falck-Zepeda, José B.
Komen, John
MacLaren, Donald
author_sort Linacre, Nicholas A.
collection Repository of Agricultural Research Outputs (CGSpace)
description Compared to both Canada and the United States, Australia has been slow to approve commercial planting of transgenic crops. Two probable reasons exist for the slow approval rate of transgenic crops in Australia. The first reason is community perceptions about the risks associated with transgenic technologies. The second is the regulatory framework currently employed to approve commercial releases. This paper examines some of the potential regulatory issues that may be affecting the review process and approval of transgenic technologies. First we provide a brief introduction to the regulatory structure in Australia, second we consider the impact of regional, national and state jurisdictions, third we argue that the regulator needs to consider the use of benefits analysis in decision making, fourth we argue for the use of probabilistic risk assessments in certain circumstances, and fifth we look at potential problems inherent in majority voting in a committee and recommend alternatives.
format Journal Article
id CGSpace172245
institution CGIAR Consortium
language Inglés
publishDate 2006
publishDateRange 2006
publishDateSort 2006
record_format dspace
spelling CGSpace1722452025-03-17T20:08:52Z Risk assessment and management of genetically modified organisms under Australia's Gene Technology Act: Considerations for regulatory development Linacre, Nicholas A. Falck-Zepeda, José B. Komen, John MacLaren, Donald risk assessment biotechnology environmental factors genetically modified organisms Compared to both Canada and the United States, Australia has been slow to approve commercial planting of transgenic crops. Two probable reasons exist for the slow approval rate of transgenic crops in Australia. The first reason is community perceptions about the risks associated with transgenic technologies. The second is the regulatory framework currently employed to approve commercial releases. This paper examines some of the potential regulatory issues that may be affecting the review process and approval of transgenic technologies. First we provide a brief introduction to the regulatory structure in Australia, second we consider the impact of regional, national and state jurisdictions, third we argue that the regulator needs to consider the use of benefits analysis in decision making, fourth we argue for the use of probabilistic risk assessments in certain circumstances, and fifth we look at potential problems inherent in majority voting in a committee and recommend alternatives. 2006 2025-01-29T12:59:37Z 2025-01-29T12:59:37Z Journal Article https://hdl.handle.net/10568/172245 en Limited Access Linacre, Nicholas A.; Falck-Zepeda, José Benjamin; Komen, John; MacLaren, Donald. 2006. Risk assessment and management of genetically modified organisms under Australia's Gene Technology Act: Considerations for regulatory development. Asian Biotechnology and Development Review 8(3): 1-16. https://www.researchgate.net/publication/283252375_Risk_assessment_and_management_of_genetically_modified_organisms_under_Australia's_gene_technology_act_Considerations_for_regulatory_development
spellingShingle risk assessment
biotechnology
environmental factors
genetically modified organisms
Linacre, Nicholas A.
Falck-Zepeda, José B.
Komen, John
MacLaren, Donald
Risk assessment and management of genetically modified organisms under Australia's Gene Technology Act: Considerations for regulatory development
title Risk assessment and management of genetically modified organisms under Australia's Gene Technology Act: Considerations for regulatory development
title_full Risk assessment and management of genetically modified organisms under Australia's Gene Technology Act: Considerations for regulatory development
title_fullStr Risk assessment and management of genetically modified organisms under Australia's Gene Technology Act: Considerations for regulatory development
title_full_unstemmed Risk assessment and management of genetically modified organisms under Australia's Gene Technology Act: Considerations for regulatory development
title_short Risk assessment and management of genetically modified organisms under Australia's Gene Technology Act: Considerations for regulatory development
title_sort risk assessment and management of genetically modified organisms under australia s gene technology act considerations for regulatory development
topic risk assessment
biotechnology
environmental factors
genetically modified organisms
url https://hdl.handle.net/10568/172245
work_keys_str_mv AT linacrenicholasa riskassessmentandmanagementofgeneticallymodifiedorganismsunderaustraliasgenetechnologyactconsiderationsforregulatorydevelopment
AT falckzepedajoseb riskassessmentandmanagementofgeneticallymodifiedorganismsunderaustraliasgenetechnologyactconsiderationsforregulatorydevelopment
AT komenjohn riskassessmentandmanagementofgeneticallymodifiedorganismsunderaustraliasgenetechnologyactconsiderationsforregulatorydevelopment
AT maclarendonald riskassessmentandmanagementofgeneticallymodifiedorganismsunderaustraliasgenetechnologyactconsiderationsforregulatorydevelopment